{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:25:26Z","timestamp":1789975526903,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Transforming growth factor-\u03b2 (TGF-\u03b2) is a multi-factorial peptide growth factor that has a vital role in the regulation of cell growth, differentiation, inflammation, and tissue repair. Quantification of biologically active TGF-\u03b2 levels in tissues is crucial to illustrate mechanisms involved in various physiological and pathological processes, but direct measurement of bioactive TGF-\u03b2 level in the tissue has been hampered by lack of reliable methods. Here, we introduced mink lung epithelial cell bioassay to quantify both active and total TGF-\u03b2 levels in serum and protein lysates from solid organs in the mouse model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Findings<\/jats:title>\n            <jats:p>Mink lung epithelial cells were stably transfected with plasminogen activator inhibitor-1 promoter\/luciferase construct, in which bioactive TGF-\u03b2 level was represented by luciferase activity. Serum total TGF-\u03b2 levels were comparable between the bioassay and enzyme-linked immunosorbent assay (ELISA), but active TGF-\u03b2 levels measured by ELISA were significantly lower than those obtained by the bioassay. Active and total TGF-\u03b2 levels in the solid organs including heart, liver, and kidney were also measured. Total TGF-\u03b2 levels were relatively comparable among these organs, but active TGF-\u03b2 levels were slightly higher in hearts and kidneys than in livers. Positive luciferase activities in the bioassay were almost completely inhibited by adding pan-TGF-\u03b2 neutralizing antibodies, suggesting its high specificity to bioactive TGF-\u03b2. We also measured myocardial TGF-\u03b2 levels after myocardial infarction and sham control by the bioassay, and compared the values with those obtained by ELISA. The bioassay demonstrated that both active and total tissue TGF-\u03b2 levels were significantly higher in post-myocardial infarction than in sham myocardium. ELISA was markedly less sensitive in detecting both active and total TGF-\u03b2 levels than our bioassay and failed to show any statistically significant difference in TGF-\u03b2 levels between myocardial infarction and sham myocardium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our data suggested that the bioassay was significantly more sensitive than ELISA in detecting active TGF-\u03b2 in serum and both active and total TGF-\u03b2 in solid organ tissues. The bioassay will be useful in investigating TGF-\u03b2 profile in various solid organs in physiological and pathological conditions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-0500-5-636","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T17:14:07Z","timestamp":1352913247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Quantification of active and total transforming growth factor-\u03b2 levels in serum and solid organ tissues by bioassay"],"prefix":"10.1186","volume":"5","author":[{"given":"Shaukat A","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,14]]},"reference":[{"key":"1997_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S1357-2725(03)00255-3","volume":"36","author":"D Javelaud","year":"2004","unstructured":"Javelaud D, Mauviel A: Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles. Int J Biochem Cell Biol. 2004, 36: 1161-1165. 10.1016\/S1357-2725(03)00255-3.","journal-title":"Int J Biochem Cell Biol"},{"key":"1997_CR2","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1096\/fj.03-1273rev","volume":"18","author":"A Leask","year":"2004","unstructured":"Leask A, Abraham DJ: TGF-beta signaling and the fibrotic response. FASEB J. 2004, 18: 816-827. 10.1096\/fj.03-1273rev.","journal-title":"FASEB J"},{"key":"1997_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","volume":"67","author":"J Massague","year":"1998","unstructured":"Massague J: TGF-beta signal transduction. Annu Rev Biochem. 1998, 67: 753-791. 10.1146\/annurev.biochem.67.1.753.","journal-title":"Annu Rev Biochem"},{"key":"1997_CR4","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1101\/gad.1350705","volume":"19","author":"J Massague","year":"2005","unstructured":"Massague J, Seoane J, Wotton D: Smad transcription factors. Genes Dev. 2005, 19: 2783-2810. 10.1101\/gad.1350705.","journal-title":"Genes Dev"},{"key":"1997_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3109\/08830189809043009","volume":"16","author":"NL McCartney-Francis","year":"1998","unstructured":"McCartney-Francis NL, Frazier-Jessen M, Wahl SM: TGF-beta: a balancing act. Int Rev Immunol. 1998, 16: 553-580.","journal-title":"Int Rev Immunol"},{"key":"1997_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-2478(02)00023-8","volume":"82","author":"A Moustakas","year":"2002","unstructured":"Moustakas A, Pardali K, Gaal A, Heldin CH: Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett. 2002, 82: 85-91. 10.1016\/S0165-2478(02)00023-8.","journal-title":"Immunol Lett"},{"key":"1997_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cardiores.2007.02.008","volume":"74","author":"M Ruiz-Ortega","year":"2007","unstructured":"Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J: TGF-beta signaling in vascular fibrosis. Cardiovasc Res. 2007, 74: 196-206. 10.1016\/j.cardiores.2007.02.008.","journal-title":"Cardiovasc Res"},{"key":"1997_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/CCO.0b013e3282f0ad0e","volume":"19","author":"M Pennison","year":"2007","unstructured":"Pennison M, Pasche B: Targeting transforming growth factor-beta signaling. Curr Opin Oncol. 2007, 19: 579-585. 10.1097\/CCO.0b013e3282f0ad0e.","journal-title":"Curr Opin Oncol"},{"key":"1997_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11926-002-0010-4","volume":"4","author":"F Verrecchia","year":"2002","unstructured":"Verrecchia F, Mauviel A: Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis. Curr Rheumatol Rep. 2002, 4: 143-149. 10.1007\/s11926-002-0010-4.","journal-title":"Curr Rheumatol Rep"},{"key":"1997_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","volume":"118","author":"R Khan","year":"2006","unstructured":"Khan R, Sheppard R: Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology. 2006, 118: 10-24. 10.1111\/j.1365-2567.2006.02336.x.","journal-title":"Immunology"},{"key":"1997_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/path.2785","volume":"223","author":"E Meulmeester","year":"2011","unstructured":"Meulmeester E, Ten Dijke P: The dynamic roles of TGF-\u03b2 in cancer. J Pathol. 2011, 223: 205-218.","journal-title":"J Pathol"},{"key":"1997_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00441-011-1189-3","volume":"347","author":"I Toma","year":"2012","unstructured":"Toma I, McCaffrey TA: Transforming growth factor-\u03b2 and atherosclerosis: interwoven atherogenic and atheroprotective aspects. Cell Tissue Res. 2012, 347: 155-175. 10.1007\/s00441-011-1189-3.","journal-title":"Cell Tissue Res"},{"key":"1997_CR13","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.transproceed.2011.01.160","volume":"43","author":"Y Tao","year":"2011","unstructured":"Tao Y, Hu L, Li S, Liu Q, Wu X, Li D, Fu P, Wei D, Luo Z: Tranilast prevents the progression of chronic cyclosporine nephrotoxicity through regulation of transforming growth factor beta\/Smad pathways. Transplant Proc. 2011, 43: 1985-1988. 10.1016\/j.transproceed.2011.01.160.","journal-title":"Transplant Proc"},{"key":"1997_CR14","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1172\/JCI200422715","volume":"114","author":"CM Ng","year":"2004","unstructured":"Ng CM, Cheng A, Myers LA, Martinez-Murillo F, Jie C, Bedja D, Gabrielson KL, Hausladen JM, Mecham RP, Judge DP, Dietz HC: TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest. 2004, 114: 1586-1592.","journal-title":"J Clin Invest"},{"key":"1997_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/sj.bjc.6603877","volume":"97","author":"LJ Hawinkels","year":"2007","unstructured":"Hawinkels LJ, Verspaget HW, van Duijn W, van der Zon JM, Zuidwijk K, Kubben FJ, Verheijen JH, Hommes DW, Lamers CB, Sier CF: Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients. Br J Cancer. 2007, 97: 398-404. 10.1038\/sj.bjc.6603877.","journal-title":"Br J Cancer"},{"key":"1997_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.bjc.6602920","volume":"94","author":"S Desruisseau","year":"2006","unstructured":"Desruisseau S, Palmari J, Giusti C, Romain S, Martin PM, Berthois Y: Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival. Br J Cancer. 2006, 94: 239-246. 10.1038\/sj.bjc.6602920.","journal-title":"Br J Cancer"},{"key":"1997_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1006\/abio.1994.1042","volume":"216","author":"M Abe","year":"1994","unstructured":"Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB: An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem. 1994, 216: 276-284. 10.1006\/abio.1994.1042.","journal-title":"Anal Biochem"},{"key":"1997_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1006\/abio.1997.2026","volume":"247","author":"MA van Waarde","year":"1997","unstructured":"van Waarde MA, van Assen AJ, Kampinga HH, Konings AW, Vujaskovic Z: Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem. 1997, 247: 45-51. 10.1006\/abio.1997.2026.","journal-title":"Anal Biochem"},{"key":"1997_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0009-8981(94)05995-4","volume":"235","author":"DJ Grainger","year":"1995","unstructured":"Grainger DJ, Mosedale DE, Metcalfe JC, Weissberg PL, Kemp PR: Active and acid-activatable TGF-beta in human sera, platelets and plasma. Clin Chim Acta. 1995, 235: 11-31. 10.1016\/0009-8981(94)05995-4.","journal-title":"Clin Chim Acta"},{"key":"1997_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nm0195-74","volume":"1","author":"DJ Grainger","year":"1995","unstructured":"Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A: The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med. 1995, 1: 74-79. 10.1038\/nm0195-74.","journal-title":"Nat Med"},{"key":"1997_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1385\/1-59259-940-0:161","volume-title":"Fibrosis Research: Methods and Protocols. Volume 117","author":"V Jurukovski","year":"2005","unstructured":"Jurukovski V, Dabovic B, Todorovic V, Chen Y, Rifkin DB: Methods for measuring TGF-\u03b2 using antibodies, cells, and mice. Fibrosis Research: Methods and Protocols. Volume 117. Edited by: Varga JB DA, Phan SH. 2005, Towata: Humana Press, 161-175."},{"key":"1997_CR22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0008-6363(03)00519-4","volume":"59","author":"T Tsuda","year":"2003","unstructured":"Tsuda T, Gao E, Evangelisti L, Markova D, Ma X, Chu ML: Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes. Cardiovasc Res. 2003, 59: 926-933. 10.1016\/S0008-6363(03)00519-4.","journal-title":"Cardiovasc Res"},{"key":"1997_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem. 1985, 150: 76-85. 10.1016\/0003-2697(85)90442-7.","journal-title":"Anal Biochem"},{"key":"1997_CR24","doi-asserted-by":"crossref","first-page":"14090","DOI":"10.1016\/S0021-9258(18)47909-4","volume":"262","author":"MD O'Connor-McCourt","year":"1987","unstructured":"O'Connor-McCourt MD, Wakefield LM: Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. J Biol Chem. 1987, 262: 14090-14099.","journal-title":"J Biol Chem"},{"key":"1997_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1083\/jcb.109.1.441","volume":"109","author":"TA McCaffrey","year":"1989","unstructured":"McCaffrey TA, Falcone DJ, Brayton CF, Agarwal LA, Welt FG, Weksler BB: Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta\/alpha 2-macroglobulin inactive complex. J Cell Biol. 1989, 109: 441-448. 10.1083\/jcb.109.1.441.","journal-title":"J Cell Biol"},{"key":"1997_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","volume":"74","author":"M Bujak","year":"2007","unstructured":"Bujak M, Frangogiannis NG: The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007, 74: 184-195. 10.1016\/j.cardiores.2006.10.002.","journal-title":"Cardiovasc Res"},{"key":"1997_CR27","doi-asserted-by":"crossref","first-page":"23048","DOI":"10.1016\/S0021-9258(18)54461-6","volume":"266","author":"MR Keeton","year":"1991","unstructured":"Keeton MR, Curriden SA, van Zonneveld AJ, Loskutoff DJ: Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J Biol Chem. 1991, 266: 23048-23052.","journal-title":"J Biol Chem"},{"key":"1997_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/08977199009037500","volume":"3","author":"PD Brown","year":"1990","unstructured":"Brown PD, Wakefield LM, Levinson AD, Sporn MB: Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors. 1990, 3: 35-43. 10.3109\/08977199009037500.","journal-title":"Growth Factors"},{"key":"1997_CR29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1096\/fasebj.11.12.9337152","volume":"11","author":"EJ Ehrhart","year":"1997","unstructured":"Ehrhart EJ, Segarini P, Tsang ML, Carroll AG, Barcellos-Hoff MH: Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation. FASEB J. 1997, 11: 991-1002.","journal-title":"FASEB J"},{"key":"1997_CR30","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1073\/pnas.92.7.2572","volume":"92","author":"N Sanderson","year":"1995","unstructured":"Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS: Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA. 1995, 92: 2572-2576. 10.1073\/pnas.92.7.2572.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1997_CR31","doi-asserted-by":"crossref","first-page":"H3020","DOI":"10.1152\/ajpheart.2000.279.6.H3020","volume":"279","author":"J Hao","year":"2000","unstructured":"Hao J, Wang B, Jones SC, Jassal DS, Dixon IM: Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol Heart Circ Physiol. 2000, 279: H3020-H3030.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1997_CR32","doi-asserted-by":"publisher","first-page":"e14145","DOI":"10.1371\/journal.pone.0014145","volume":"5","author":"R Rodrigues Diez","year":"2010","unstructured":"Rodrigues Diez R, Rodrigues-Diez R, Lavoz C, Rayego-Mateos S, Civantos E, Rodriguez-Vita J, Mezzano S, Ortiz A, Egido J, Ruiz-Ortega M: Statins inhibit angiotensin II\/Smad pathway and related vascular fibrosis, by a TGF-\u03b2-independent process. PLoS One. 2010, 5: e14145-10.1371\/journal.pone.0014145.","journal-title":"PLoS One"},{"key":"1997_CR33","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1161\/01.RES.0000218782.52610.dc","volume":"98","author":"W Wang","year":"2006","unstructured":"Wang W, Huang XR, Canlas E, Oka K, Truong LD, Deng C, Bhowmick NA, Ju W, Bottinger EP, Lan HY: Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res. 2006, 98: 1032-1039. 10.1161\/01.RES.0000218782.52610.dc.","journal-title":"Circ Res"},{"key":"1997_CR34","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00384-007-0342-7","volume":"22","author":"E Angenete","year":"2007","unstructured":"Angenete E, Langenskiold M, Palmgren I, Falk P, Oresland T, Ivarsson ML: Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients. Int J Colorectal Dis. 2007, 22: 1331-1338. 10.1007\/s00384-007-0342-7.","journal-title":"Int J Colorectal Dis"},{"key":"1997_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1465-9921-11-67","volume":"11","author":"D Dromann","year":"2010","unstructured":"Dromann D, Rupp J, Rohmann K, Osbahr S, Ulmer AJ, Marwitz S, Roschmann K, Abdullah M, Schultz H, Vollmer E, Zabel P, Dalhoff K, Goldmann T: The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae. Respir Res. 2010, 11: 67-10.1186\/1465-9921-11-67.","journal-title":"Respir Res"},{"issue":"Suppl 1","key":"1997_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00005344-200110001-00011","volume":"38","author":"M Ma","year":"2001","unstructured":"Ma M, Watanabe K, Wahed MI, Inoue M, Sekiguchi T, Kouda T, Ohta Y, Nakazawa M, Yoshida Y, Yamamoto T, Hanawa H, Kodama M, Fuse K, Aizawa Y: Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril. J Cardiovasc Pharmacol. 2001, 38 (Suppl 1): 51-54.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1997_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00392-010-0248-1","volume":"100","author":"M Behnes","year":"2011","unstructured":"Behnes M, Hoffmann U, Lang S, Weiss C, Ahmad-Nejad P, Neumaier M, Borggrefe M, Brueckmann M: Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure. Clin Res Cardiol. 2011, 100: 335-342. 10.1007\/s00392-010-0248-1.","journal-title":"Clin Res Cardiol"},{"key":"1997_CR38","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.112.108282","volume":"125","author":"IJ Benjamin","year":"2012","unstructured":"Benjamin IJ: Targeting endoglin, an auxiliary TGF-\u03b2 coreceptor, to prevent fibrosis and heart failure. Circulation. 2012, 125: 2689-2691. 10.1161\/CIRCULATIONAHA.112.108282.","journal-title":"Circulation"},{"key":"1997_CR39","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1172\/JCI114932","volume":"86","author":"LM Wakefield","year":"1990","unstructured":"Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB: Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest. 1990, 86: 1976-1984. 10.1172\/JCI114932.","journal-title":"J Clin Invest"},{"key":"1997_CR40","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.ejca.2011.05.001","volume":"47","author":"MC Hartmann","year":"2011","unstructured":"Hartmann MC, Dwyer RM, Costello M, Potter SM, Curran C, Hennessy E, Newell J, Griffin DG, Kerin MJ: Relationship between CCL5 and transforming growth factor-\u03b21 (TGFbeta1) in breast cancer. Eur J Cancer. 2011, 47: 1669-1675. 10.1016\/j.ejca.2011.05.001.","journal-title":"Eur J Cancer"},{"key":"1997_CR41","first-page":"356","volume":"2","author":"F Baratelli","year":"2010","unstructured":"Baratelli F, Lee JM, Hazra S, Lin Y, Walser TC, Schaue D, Pak PS, Elashoff D, Reckamp K, Zhang L, Fishbein MC, Sharma S, Dubinett SM: PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. Am J Transl Res. 2010, 2: 356-367.","journal-title":"Am J Transl Res"},{"key":"1997_CR42","first-page":"288","volume":"7","author":"ZZ Dong","year":"2008","unstructured":"Dong ZZ, Yao DF, Yao M, Qiu LW, Zong L, Wu W, Wu XH, Yao DB, Meng XY: Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2008, 7: 288-295.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1997_CR43","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/heart.86.6.701","volume":"86","author":"JE Sanderson","year":"2001","unstructured":"Sanderson JE, Lai KB, Shum IO, Wei S, Chow LT: Transforming growth factor-beta(1) expression in dilated cardiomyopathy. Heart. 2001, 86: 701-708. 10.1136\/heart.86.6.701.","journal-title":"Heart"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:54:46Z","timestamp":1630533286000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-5-636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,14]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1997"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-5-636","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,14]]},"assertion":[{"value":"2 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"636"}}